Ligand Pharmaceuticals (LGND) Non-Current Debt (2011 - 2026)
Ligand Pharmaceuticals' (LGND) quarterly Non-Current Debt came in at $446.9 million in Q1 2026, little changed quarter-over-quarter from $446.2 million in Q4 2025.
Ligand Pharmaceuticals (LGND) Non-Current Debt (2011 - 2026) Analysis & Trends
Ligand Pharmaceuticals has disclosed Non-Current Debt across 7 years of filings, most recently posting $446.9 million for Q1 2026.
- Non-Current Debt for Q1 2026 came in at $446.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $446.9 million (changed N/A YoY), and the FY2025 annual result was $446.2 million, changed N/A from the prior year.
- Non-Current Debt came in at $446.9 million for Q1 2026 at Ligand Pharmaceuticals, roughly flat from $446.2 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $446.9 million in Q1 2026 to a low of $445.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ligand Pharmaceuticals | 5.47 Bn | 4.69 Bn | 48.45 Mn | 446.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 446.90 Mn |
| Mar 31, 2026 | 446.90 Mn |
| Dec 31, 2025 | 446.19 Mn |
| Dec 31, 2025 | 446.19 Mn |
| Sep 30, 2025 | 445.49 Mn |
| Sep 30, 2025 | 445.49 Mn |
| Dec 31, 2015 | 205.37 Mn |
| Dec 31, 2015 | 205.37 Mn |
| Dec 31, 2014 | 195.91 Mn |
| Dec 31, 2014 | 195.91 Mn |
| Jun 30, 2013 | 1.97 Mn |
| Jun 30, 2013 | 1.97 Mn |
| Mar 31, 2013 | 5.49 Mn |
| Mar 31, 2013 | 5.49 Mn |
| Dec 31, 2012 | 13.44 Mn |
| Dec 31, 2012 | 13.44 Mn |
| Sep 30, 2012 | 17.88 Mn |
| Sep 30, 2012 | 17.88 Mn |
| Mar 31, 2012 | 26.44 Mn |
| Mar 31, 2012 | 26.44 Mn |